GLPBio

Proteins

Research Areas

Products Related to Proteins(726)

  • GC64039 structure
    GC64039Disitamab vedotin
    CAS: 2136633-23-1
    Purity: >97.00%

    Disitamab vedotin is an antibody-drug conjugate (ADC) targeting HER2 protein that is comprised of hertuzumab coupling monomethyl auristatin E (MMAE) via a cleavable linker.

  • GC64119 structure
    GC64119Saponarin
    CAS: 20310-89-8
    Purity: >98.00%

    Saponarin is a natural flavonoid isolated from Gypsophila trichotoma, with antioxidant, anti-inflammatory and hepatoprotective activities.

  • GC64161 structure
    GC64161Calcium glycerophosphate
    CAS: 27214-00-2
    Purity: >98.00%

    Calcium glycerophosphate is an inhibitor of intestinal alkaline phosphatase F3.

  • GC64338 structure
    GC64338LYP-IN-1
    CAS: 1404436-51-6
    Purity: >98.50%

    LYP-IN-1 is a potent, selective and specific LYP inhibitor with a Ki and an IC50 of 110 nM and 0.259 μM, respectively.

  • GC64376 structure
    GC64376GDC-1971
    CAS: 2377352-49-1
    Purity: >98.00%

    GDC-1971 (compound 199) is a SHP2 inhibitor.

  • GC64556 structure
    GC64556PTP1B-IN-15
    CAS: 765317-71-3
    Purity: >98.00%

    PTP1B-IN-15 is a potent and selective inhibitor of protein tyrosine phosphatase 1B (PTP1B).

  • GC64605 structure
    GC64605MY33-3 hydrochloride
    CAS: 2204280-42-0
    Purity: >99.00%

    MY33-3 hydrochloride is a potent and selective inhibitor of receptor protein tyrosine phosphatase (RPTP)β/ζ, with an IC50 of ~0.1 μM.

  • GC64930 structure
    GC64930Sacituzumab govitecan
    CAS: 1491917-83-9
    Purity: >98.00%

    Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. Sacituzumab govitecan shows anticancer activity.

  • GC64936 structure
    GC64936TD52 dihydrochloride
    Purity: >98.00%

    TD52 dihydrochloride, an Erlotinib derivative, is an orally active, potent cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibitor. TD52 dihydrochloride mediates the apoptotic effect in triple-negative breast cancer (TNBC) cells via regulating the CIP2A/PP2A/p-Akt signalling pathway. TD52 dihydrochloride indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter. TD52 dihydrochloride has less p-EGFR inhibition and has potent anti-cancer activity.

  • GC64948 structure
    GC64948CD38 inhibitor 1
    CAS: 1700637-55-3
    Purity: >99.00%

    CD38 inhibitor 1 is a potent CD38 inhibitor with an IC 50 value of 1.9nM for mouse CD38.

  • GC65025 structure
    GC65025BCI hydrochloride
    CAS: 95130-23-7
    Purity: >99.00%

    BCI ((E)-BCI) hydrochloride is a DUSP6 (dual specificity phosphatase 6) inhibitor.

  • GC65097 structure
    GC65097ARL67156 trisodium hydrate
    Purity: >99.00%

    ARL67156 (FPL 67156) trisodium hydrate is a selective ecto-ATPase inhibitor.

  • GC65098 structure
    GC65098ARL67156 triethylamine
    Purity: >99.50%

    ARL67156 (FPL 67156) triethylamine is a selective ecto-ATPase inhibitor.

  • GC65157 structure
    GC65157Naphthol AS-BR
    CAS: 91-92-9
    Purity: >98.00%

    Naphthol AS-BR is a substrate for the histochemical demonstration of acid and alkaline phosphatase.

  • GC65260 structure
    GC65260EDP-305
    CAS: 1933507-63-1
    Purity: >96.00%

    EDP-305 is an orally active, potent and selective farnesoid X receptor (FXR) agonist, with EC50 values of 34 nM (chimeric FXR in CHO cells) and 8 nM (full-length FXR in HEK cells).

  • GC65286 structure
    GC65286INX-SM-6
    CAS: 2734878-16-9
    Purity: >98.00%

    INX-SM-6 can be used for targeted delivery of anti-inflammatory agent.

  • GC65287 structure
    GC65287INX-SM-56
    CAS: 2734878-18-1
    Purity: >98.00%

    INX-SM-56 is an anti-VISTA antibody drug conjugate and can be used for targeted delivery of anti-inflammatory agents.

  • GC65308 structure
    GC65308SHIP2-IN-1
    CAS: 2252247-80-4
    Purity: >99.00%

    SHIP2-IN-1 is a potent SHIP2 inhibitor, inhibits SHIP2 activity, with an IC50 of 2 ?M.

  • GC65394 structure
    GC653947-BIA
    CAS: 1313403-49-4
    Purity: >98.00%

    7-BIA is a receptor-type protein tyrosine phosphatase D (PTPRD) inhibitor with an IC50 of ~1-3 μM.

  • GC65533 structure
    GC65533SHP394
    CAS: 2055757-40-7
    Purity: >99.00%

    SHP394 is an orally active, selective and allosteric inhibitor of SHP2, with an IC50 of 23 nM.

  • GC65542 structure
    GC65542NSC-87877 disodium
    CAS: 56932-43-5
    Purity: >98.00%

    NSC-87877 disodium is a potent inhibitor of Shp2 and Shp1 protein tyrosine phosphatases (SH-PTP2 and SH-PTP1), with IC50 values of 0.318 μM, 0.355 μM shp2 and shp1, respectively. NSC-87877 also inhibits dual-specificity phosphatase 26 (DUSP26).

  • GC67798 structure
    GC67798MLS-0437605
    CAS: 862975-18-6
    Purity: >98.00%
  • GC67938 structure
    GC67938Guaiacin
    CAS: 36531-08-5
    Purity: >98.00%
  • GC68296 structure
    GC68296Brentuximab vedotin
    CAS: 914088-09-8
    Purity: >99.50%